Sort
50,496 grants matching “lung cancer”
Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response
$576,453Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
MULTIPRONGED COTARGETING OF ALK/ROS1 AND COMPENSATORY FOCAL ADHESION KINASES IN LUNG CANCER AS A PREEMPTIVE STRIKE TO PREVENT DEVELOPMENT OF DRUG RESISTANCE.
$576,450H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. · · FY2022 · Defense Health Agency
Radiologist-Centered Artificial Intelligence (RCAI) for Lung Cancer Screening and Diagnosis
$576,431Ulas Bagci · Northwestern University At Chicago · R01 · FY2020 · CA
The role of Galectin-1 in shaping the immune suppressive landscape in head and neck cancer
$576,429Quynh-Thu X Le · Stanford University · R01 · FY2025 · DE
Defining Cancer Intervention Targets by Functional Genomics Analysis of Outbred F1 Mice
$576,403Jennifer B Jacob · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2025 · CA
The role of Galectin-1 in shaping the immune suppressive landscape in head and neck cancer
$576,376Quynh-Thu X Le · Stanford University · R01 · FY2023 · DE
Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Patients with Cancer
$576,359Susan Mazanec · Case Western Reserve University · R37 · FY2021 · CA
Thioredoxin derivatives for radiation mitigation
$576,303Yubin Kang · Duke University · U01 · FY2025 · AI
Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Patients with Cancer
$576,246Susan Mazanec · Case Western Reserve University · R37 · FY2020 · CA
Exosomes as carriers of cancer therapeutics
$576,222Rajagopal Ramesh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2021 · CA
Histone Methyltransferases as a Target for Lung Cancer Prevention
$576,204Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2014 · CA
Hybrid Nanoparticles in Imaging and Therapy of Prostate*
$576,194Kattesh V Katti · University Of Missouri-Columbia · R01 · FY2008 · CA
The MYC Transcription Factor Network and the Path to Cancer
$576,145Robert Neil Eisenman · Fred Hutchinson Cancer Research Center · R35 · FY2021 · CA
Molecular Imaging and Targeted Therapy of HER2-Positive Breast Cancers
$576,145Jacek Capala · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Preclinical Time domain Fluorescence Tomography Platform
$576,080Anand T.n. Kumar · Massachusetts General Hospital · R01 · FY2017 · CA
HER2-mediated delivery of cytotoxic agents in solid tumors
$576,031Bob T Li · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
HER2-mediated delivery of cytotoxic agents in solid tumors
$576,029Bob T Li · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
The Tumor Suppressor Role of SMARCA4 in SCCOHT
$576,025Bernard E. Weissman · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
Molecular Signatures of Lethal and Indolent Prostate Cancer
$576,014Mark A. Rubin · Weill Medical Coll Of Cornell Univ · R01 · FY2014 · CA
Developmental pathways regulating adult lung quiescence
$575,995Edward E Morrisey · University Of Pennsylvania · R01 · FY2019 · HL
Optimizing remotely delivered Smoking Cessation Services for Low-Income Smokers
$575,973Danielle Erin McCarthy · University Of Wisconsin-Madison · R01 · FY2019 · CA
Nonmyeloablative allogeneic PBSC in globin disorders
$575,937John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
The Antigen Targeting Core
$575,890Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Mathematical modeling of metabolism rewiring in cancer eco-evolution and metastasis tropism
$575,679Joao Xavier · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Mathematical modeling of metabolism rewiring in cancer eco-evolution and metastasis tropism
$575,679Joao Xavier · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA